Why the study?
Do various intravenous beta-blockers prolong ventricular refractoriness (class III action) in open-chested beagle dogs?
Do various intravenous beta-blockers prolong ventricular refractoriness (class III action) in open-chested beagle dogs?
Nadolol and oxprenolol, similar to sotalol, demonstrate class III antiarrhythmic properties by prolonging ventricular refractoriness in a canine model.
Answers are grounded in this paper and cite their sources.
Preclinical canine data do not support practice change; leaves open human translation of class III effects.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Taggart et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: